• Skip to main content

The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.

We use cookies

Necessary cookies

Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

Analytics cookies

Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.

ON OFF

Clarity

Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.

ON OFF

Privacy policy


  • Translational Research Initiative
  • Success Stories
  • VascuX
  • SOLASTA Bio
  • Nebu-Flow
  • VascuX
  • SITUATE
  • SalmoSim
  • Mitotargin
  • Disruptyx
  • Everyday Clean
  • Increasing vaccine access
  • Sci-Seedlets
  • XR Life Science
  • Keltic Pharma Therapeutics
  • Glox Therapeutics
  • Study
  • Research
  • Explore
  • Connect
Search icon
Close menu icon
Menu icon bar 1 Menu icon bar 2 Menu icon bar 3
University of Glasgow logo small University of Glasgow logo
  • Home
  • Colleges
  • College of Medical, Veterinary & Life Sciences
  • Research and Innovation
  • Translational Research Initiative
  • Success Stories
  • VascuX

Research and Innovation

  • Translational Research Initiative
  • Success Stories
  • VascuX
  • SOLASTA Bio
  • Nebu-Flow
  • VascuX
  • SITUATE
  • SalmoSim
  • Mitotargin
  • Disruptyx
  • Everyday Clean
  • Increasing vaccine access
  • Sci-Seedlets
  • XR Life Science
  • Keltic Pharma Therapeutics
  • Glox Therapeutics

VascuX: The Journey to Revolutionizing Vascular Health Monitoring

VascuX is a University of Glasgow research group developing innovative vascular sensing and therapy technology focused on implantable medical devices. This revolutionary technology will ultimately diagnose and treat clogged arteries before the blockage becomes symptomatic. 

The Vision 

VascuX began with a vision to transform vascular health monitoring. Dr. John Mercer and Dr. Steven Neale from the University of Glasgow identified a critical need for early detection and treatment of vascular blockages, particularly for patients with chronic conditions. 

Development and features

The journey started with extensive research into the challenges faced by patients with cardiovascular diseases. The team focused on integrating advanced sensors and telemetry into implantable devices. This required a multidisciplinary approach, combining expertise in biomedical engineering, data science, and clinical practice. 

Developing the VascuX technology involved rigorous prototyping and testing. The team created multiple iterations of their devices, each time improving their functionality and reliability. They conducted extensive pre-clinical trials to ensure the safety and efficacy of the technology. 

Support from the College of Medical, Veterinary & Life Sciences (MVLS)

The College of Medical, Veterinary & Life Sciences (MVLS) at the University of Glasgow played a crucial role in supporting the VascuX project. MVLS provided essential resources and funding through various initiatives, including the Translational Research Initiative (TRI). This support enabled the team to conduct preliminary translational work, prototype development, and pre-clinical trials.  

Impact and Achievements 

The innovative journey of VascuX has led to a groundbreaking platform that offers real-time monitoring and early detection of vascular blockages. 

Future Prospects  

The team continues to work on enhancing the technology, aiming to integrate therapeutic interventions. Their ultimate goal is to revolutionize the treatment of vascular diseases, improving patient outcomes and reducing healthcare costs. 

VascuX website

Learn more about Dr John Mercer

Learn more about Dr Steven Neale

Explore More About Advanced Diagnostics and Therapeutics

Advanced Diagnostics and Therapeutics aims to pioneer development and delivery of the next generation of novel human and animal clinical interventions.

Advanced Diagnostics and Therapeutics

Back to the top

STUDY

  • Subjects A-Z
  • Undergraduate
  • Postgraduate
  • Online study
  • Short courses
  • International students
  • Student life
  • Scholarships and funding
  • Visit us / Open Days

RESEARCH

  • Research units A-Z
  • Research opportunities A-Z
  • Glasgow Research Beacons
  • Research strategy & policies
  • Research excellence
  • Our research environment

EXPLORE

  • Meet World Changing Glasgow
  • City of Glasgow
  • Visit us
  • Accessibility
  • Maps and travel
  • News 
  • Events
  • Schools
  • Colleges
  • Services
  • Library
  • University strategies

CONNECT

  • Staff A-Z
  • Information for our alumni
  • Support us
  • Business & innovation
  • Community and public engagement
  • Social Media listings
  • Ask a student
  • Complaints

JOBS AT GLASGOW

  • Current vacancies

University of Glasgow

  • Facebook
  • Bluesky
  • Instagram
  • YouTube
  • Twitter
  • tiktok
  • Linkedin
  • bilibili
  • Little Red Book
  • WeChat
  • Weibo

The University of Glasgow is a registered Scottish charity: Registration Number SC004401

Research and Innovation

  • Contact us

Legal

  • Accessibility statement
  • Freedom of information
  • FOI publication scheme
  • Modern Slavery Statement
  • Privacy and cookies
  • Terms of use

Current students

  • MyGlasgow Students

Staff

  • MyGlasgow Staff
together against gender-based violence